Difference between revisions of "Team:ASIJ Tokyo"
| Line 56: | Line 56: | ||
<p>A1-AT<br>de<span id="red">LIVER</span>y </p> | <p>A1-AT<br>de<span id="red">LIVER</span>y </p> | ||
</div> | </div> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/e/ed/T--ASIJ_Tokyo--liverlogocut.png" id="liver" | + | <img src="https://static.igem.org/mediawiki/2018/e/ed/T--ASIJ_Tokyo--liverlogocut.png" id="liver"> |
<div id="subtitle"> | <div id="subtitle"> | ||
<h1> Using Stem Cell and CRISPR Technology to Combat <br> Alpha-1 Antitrypsin Deficiency </h1> | <h1> Using Stem Cell and CRISPR Technology to Combat <br> Alpha-1 Antitrypsin Deficiency </h1> | ||
Revision as of 07:21, 31 August 2018
A1-AT
deLIVERy
